In The First Year Of The Change Of Ownership Of ST Renfu, The Leading Anesthetic Drug Company: Net Profit Increased By Nearly 40%, Revenue Fell Slightly
Reporter of Every Journal: Chen Qing Editor of Every Journal: Yang Yi On March 30, ST Renfu (SH600079, formerly known as Renfu Pharmaceutical), a leading company in the field of domestic anesthetics, disclosed its 2025 annual report: net profit increased by 39.53% year-on-year.












